Amanda F. Baker - Concepedia

Author

Amanda F. Baker

Also Known As

A Baker, A F Baker, A. Baker, A. F. Baker, A.F. Baker, Alex T Baker, Amanda Baker, Amanda F Baker, Amanda F. Baker, Annika E. Baker

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

University of Arizona University of Arizona Cancer Center The University of Texas MD Anderson Cancer Center Moffitt Cancer Center Arizona Oncology

About

Amanda F. Baker is an author at University of Arizona specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	1.4K
2	Biochemistry	4	4	217
3	Allergy	2	2	226
4	Engineering	1	1	12
5	Health Sciences	1	1	21

Amanda F. Baker

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127 Tomislav Dragovich, Sheryl McCoy, Cecilia M. Fenoglio‐Preiser, Journal of Clinical Oncology	2006	313
Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Amanda F. Baker, Claire M. Payne, Margaret M. Briehl, PubMed Redox Protein ThioredoxinHuman Thioredoxin CdnaOncogenic AgentCell SignalingMedicine	1997	245
Stability of Phosphoprotein as a Biological Marker of Tumor Signaling Amanda F. Baker, Tomislav Dragovich, Nathan T. Ihle, Clinical Cancer Research	2005	168
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non–small cell lung cancer xenografts Nathan T. Ihle, Gillian Paine-Murrieta, Margareta Berggren, Molecular Cancer Therapeutics	2005	150
Dynamic Contrast-Enhanced and Diffusion MRI Show Rapid and Dramatic Changes in Tumor Microenvironment in Response to Inhibition of HIF-1α Using PX-478 Bénédicte F. Jordan, Matthew Runquist, Natarajan Raghunand, Neoplasia	2005	128
Thioredoxin Peroxidase-1 (peroxiredoxin-1) Is Increased in Thioredoxin-1 Transfected Cells and Results in Enhanced Protection against Apoptosis Caused by Hydrogen Peroxide but Not by Other Agents Including Dexamethasone, Etoposide, and Doxorubicin Margareta Berggren, Bryan Husbeck, Betty K. Samulitis, Archives of Biochemistry and Biophysics InflammationAllergyRedox RegulatorMedicineApoptosis	2001	117
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination Ramesh K. Ramanathan, James L. Abbruzzese, Tomislav Dragovich, Cancer Chemotherapy and Pharmacology Advanced CancerOncologyPancreatic CancerMedicinePathology	2010	115
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules Qian Liu, Jessica D. Sun, Jingli Wang, Cancer Chemotherapy and Pharmacology Translational MedicineHypoxia (Medicine)PharmacologyHypoxia-activated ProdrugClinical Pharmacology	2012	113
Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Margaret E. Tome, Amanda F. Baker, Garth Powis, PubMed Catalase-overexpressing CellsLipid PeroxidationApoptosisImmunologyCell Death	2001	109
A Phase I Pharmacokinetic and Pharmacodynamic Study of PX-12, a Novel Inhibitor of Thioredoxin-1, in Patients with Advanced Solid Tumors Ramesh K. Ramanathan, D. Lynn Kirkpatrick, Chandra P. Belani, Clinical Cancer Research	2007	102

Page 1